Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)
Ratios

SAB Biotherapeutics (SABSW) Other Gross PP&E Adjustments (2020 - 2025)

SAB Biotherapeutics' Other Gross PP&E Adjustments history spans 6 years, with the latest figure at $24.2 million for Q4 2025.

  • For Q4 2025, Other Gross PP&E Adjustments rose 3.15% year-over-year to $24.2 million; the TTM value through Dec 2025 reached $24.2 million, up 3.15%, while the annual FY2025 figure was $24.2 million, 3.15% up from the prior year.
  • Other Gross PP&E Adjustments reached $24.2 million in Q4 2025 per SABSW's latest filing, down from $27.1 million in the prior quarter.
  • In the past five years, Other Gross PP&E Adjustments ranged from a high of $28.9 million in Q3 2024 to a low of $3.0 million in Q1 2022.
  • Average Other Gross PP&E Adjustments over 5 years is $22.4 million, with a median of $26.1 million recorded in 2024.
  • The largest YoY upside for Other Gross PP&E Adjustments was 818.56% in 2023 against a maximum downside of 10.4% in 2023.
  • A 5-year view of Other Gross PP&E Adjustments shows it stood at $4.4 million in 2021, then soared by 497.13% to $26.4 million in 2022, then dropped by 10.4% to $23.7 million in 2023, then decreased by 0.94% to $23.4 million in 2024, then grew by 3.15% to $24.2 million in 2025.
  • Per Business Quant, the three most recent readings for SABSW's Other Gross PP&E Adjustments are $24.2 million (Q4 2025), $27.1 million (Q3 2025), and $26.4 million (Q2 2025).